HN user

perchance

14 karma
Posts0
Comments6
View on HN
No posts found.
Theranos 13 years ago

management resembling zombies... asking for people's blood....

aha!... now we are getting somewhere.

Theranos 13 years ago

I agree. Building a medical device and/or diagnostics company is not a joke.

NIH and NSF are often criticized for slow decisions, but a major reason for that is: experimental science is difficult and slow. Software people find this hard to comprehend, e.g. why would it take 10 years to find a new treatment? That's because you find an affected family (if it's hereditary), find appropriate controls, map the mutation, make a mouse model, use the mouse model to screen for pharmacological agents, and return to humans for testing them.

Microryza needs a vetting mechanism, at the very minimum, perhaps a dedicated science advisory board. Otherwise it runs a high risk of becoming a platform for snake oil salespeople.